256 related articles for article (PubMed ID: 11757070)
1. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
David SA
J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
[TBL] [Abstract][Full Text] [Related]
2. Development of small-molecule endotoxin sequestering agents.
David SA; Sil D
Subcell Biochem; 2010; 53():255-83. PubMed ID: 20593271
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships in lipopolysaccharide neutralizers: design, synthesis, and biological evaluation of a 540-membered amphipathic bisamide library.
Burns MR; Jenkins SA; Wood SJ; Miller K; David SA
J Comb Chem; 2006; 8(1):32-43. PubMed ID: 16398551
[TBL] [Abstract][Full Text] [Related]
4. Functionalized dendrimers as endotoxin sponges.
Cromer JR; Wood SJ; Miller KA; Nguyen T; David SA
Bioorg Med Chem Lett; 2005 Mar; 15(5):1295-8. PubMed ID: 15713373
[TBL] [Abstract][Full Text] [Related]
5. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
Rosenfeld Y; Lev N; Shai Y
Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling analysis of the interaction of novel bis-cationic ligands with the lipid A moiety of lipopolysaccharide.
Guo JX; Wood SJ; David SA; Lushington GH
Bioorg Med Chem Lett; 2006 Feb; 16(3):714-7. PubMed ID: 16266804
[TBL] [Abstract][Full Text] [Related]
7. Lysine-spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants.
Burns MR; Wood SJ; Miller KA; Nguyen T; Cromer JR; David SA
Bioorg Med Chem; 2005 Apr; 13(7):2523-36. PubMed ID: 15755654
[TBL] [Abstract][Full Text] [Related]
8. Novel endotoxin-sequestering compounds with terephthalaldehyde-bis-guanylhydrazone scaffolds.
Khownium K; Wood SJ; Miller KA; Balakrishna R; Nguyen TB; Kimbrell MR; Georg GI; David SA
Bioorg Med Chem Lett; 2006 Mar; 16(5):1305-8. PubMed ID: 16377188
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
Andrä J; Gutsmann T; Garidel P; Brandenburg K
J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for endotoxin neutralization by amphipathic peptides derived from the alpha-helical cationic core-region of NK-lysin.
Brandenburg K; Garidel P; Fukuoka S; Howe J; Koch MH; Gutsmann T; Andrä J
Biophys Chem; 2010 Aug; 150(1-3):80-7. PubMed ID: 20153101
[TBL] [Abstract][Full Text] [Related]
11. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the development of neutralizing therapies for sepsis].
Florencia Henning M; Garda H; Bakás L
Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
[TBL] [Abstract][Full Text] [Related]
13. The generalized endotoxic principle.
Seydel U; Hawkins L; Schromm AB; Heine H; Scheel O; Koch MH; Brandenburg K
Eur J Immunol; 2003 Jun; 33(6):1586-92. PubMed ID: 12778476
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.
Bhunia A; Mohanram H; Bhattacharjya S
Biopolymers; 2009; 92(1):9-22. PubMed ID: 18844294
[TBL] [Abstract][Full Text] [Related]
15. A case for an endotoxic conformation.
Seydel U; Brandenburg K; Rietschel ET
Prog Clin Biol Res; 1994; 388():17-30. PubMed ID: 7831357
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
17. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
Wiese A; Gutsmann T; Seydel U
J Endotoxin Res; 2003; 9(2):67-84. PubMed ID: 12803879
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of endotoxin antagonism.
Lazaron V; Dunn DL
World J Surg; 2002 Jul; 26(7):790-8. PubMed ID: 11948366
[TBL] [Abstract][Full Text] [Related]
19. The physicochemistry of endotoxins in relation to bioactivity.
Gutsmann T; Schromm AB; Brandenburg K
Int J Med Microbiol; 2007 Sep; 297(5):341-52. PubMed ID: 17452014
[TBL] [Abstract][Full Text] [Related]
20. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
